Navigation Links
Ivera Medical Announces Patent Award for Curos® Port Protectors
Date:6/13/2012

SAN DIEGO, June 13, 2012 /PRNewswire/ -- Ivera Medical Corporation announced today that the United States Patent & Trademark Office (USPTO) will issue a new continuation patent for its innovative Curos® disinfecting port protector technology on June 26, 2012.  U.S. Patent No. 8,206,514 will cover key aspects of disinfecting caps designed to be used with luer-activated IV valves to disinfect and clean the IV port.

IV therapy is the primary route for drug therapy in the acute care setting. However, traditional IV access management techniques, including "scrub the hub" protocols have failed to protect patients as evidenced by the approximately 87 percent of bloodstream infections associated with the presence of some type of intravascular device.

Ivera Medical's Curos Port Protector is a simple, innovative, disposable medical device that effectively disinfects luer-activated needleless valves, killing the organisms associated with patient bloodstream infection. With two dispenser options—the Curos Strip or individual Curos—nurses can conveniently comply with disinfection protocols by simply peeling the foil seal off the distinctive green cap and twisting Curos over the top of any luer-activated IV access port or needleless valve. Inside Curos a 70% IPA (isopropyl alcohol) saturated sponge-like foam automatically provides effective, consistent and reliable passive disinfection of the port. The use of Curos eliminates training and technique-related issues while providing an unequivocal indicator that an IV access site is clean.

"This patent further strengthens our patent protection within the disinfection cap arena," stated Bob Rogers, chief executive officer of Ivera Medical. "We continue to develop our intellectual property to ensure that Ivera is well-positioned to bring new and better disinfection solutions to market."

About Ivera Medical

Ivera Medical Corporation is focused on the design, development, manufacture, marketing and sale of products that help healthcare providers reduce facility-acquired patient infections. Curos®, manufactured in Carlsbad, CA, is the first disinfecting cap to be marketed in the U.S. and has received FDA's 510(k) market clearance. For more information about Curos and Ivera Medical, visit the website at http://www.iveramed.com.

Contact:
Bob Rogers
Chief Executive Officer
Ivera Medical Corp.
Bob.rogers@iveramed.com
760-612-6090


'/>"/>
SOURCE Ivera Medical Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ivera Medical Corporation Denies Patent Infringement Allegations
2. Oriel STAT A MATRIX Welcomes New Global Practice Head for Medical Devices and Life Sciences
3. Global Market for Medical Imaging Equipment to Reach $25.3 Billion as Retiring Boomers and Emerging Markets Demand Better Healthcare
4. This Week: UBM Canon Presents an Online Event and Conference Dedicated to Emerging Trends in Medical Device Outsourcing/Contract Manufacturing
5. Aethlon Medical (AEMD) Note: Cancer Research Discovery - Melanoma Exosomes Fuel Organ Metastasis
6. NexGen Biomedical, Inc. Provides New Insights Into Jett Travoltas Seizure Related Death
7. Emerging Trends in Medical Device Outsourcing and Contract Manufacturing
8. Nonin Medicals Tissue Oximetry System Recognized at Premier Healthcare Alliance Innovation Celebration
9. Nonin Medical, Inc. Announces U.S. Market Release of EQUANOX™ Advance Model 8004CB Series Sensor for Neonatal, Pediatric Patients
10. Aircraft Medical Launches the McGRATH® MAC 2 Blade for Paediatric Patients
11. New Medical Device Study Offers Key Marketing Budget and Staffing Metrics to Promote Effective Use of Resources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... Feb 23, 2017 Research and Markets has ... Analysis and Strategies - 2016" report to their offering. ... The latest research ... drug pricing data and benchmarks in the global Autism Spectrum Disorder ... What are the key drugs marketed for Autism Spectrum ...
(Date:2/23/2017)... , Feb. 23, 2017 ITL Limited, ( ASX: ITD ... results for the half year ended 31 December 2016 compared with ... Update" presentation can be viewed here . ... 2015: $1.04m; up 104%) Earnings per share of ... Revenue of $17.5m (Dec 2015: $15.7m; up 11%) ...
(Date:2/23/2017)... Feb 23, 2017 Research and Markets has ... and Strategies - 2016" report to their offering. ... The latest research Oesophageal ... data and benchmarks in the global Oesophageal Cancer market. ... What are the key drugs marketed for Oesophageal Cancer and their ...
Breaking Medicine Technology:
(Date:2/26/2017)... ... February 26, 2017 , ... ... in North America, today announced it would be offering some it’s exclusive product ... itself on crafting quality and unique baby clothing/feeding products, will team up with ...
(Date:2/26/2017)... ... February 26, 2017 , ... Functional imaging data supports ... a study released today at the 1st Pan American Parkinson’s and Movement Disorders ... be effective in improving cognitive function in PD patients. This study, led by ...
(Date:2/24/2017)... ... 24, 2017 , ... Houston dentist , Dr. Behzad ... Dental Center. Currently, patients can get single dental implants for $3,599 and All ... learn more about these offers by contacting Antoine Dental Center. Both of these ...
(Date:2/24/2017)... ... February 24, 2017 , ... Dr. ... has officially announced the appointment of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., ... (LUCOM), beginning April 10. Dr. Bell comes to Liberty from the Ohio ...
(Date:2/24/2017)... , ... February 24, 2017 , ... Healthcare Associates ... Medical Center at Craig Ranch building at 8080 State Highway 121, Suite 210, McKinney, ... with easy access to Highway 121. , As the practice has grown, the need ...
Breaking Medicine News(10 mins):